Table 1.
Demographic and clinical characteristics of 627 medical/radiation (MED/RAD) oncology and transplant (SCT) patients
|
Clinical service |
||||
|---|---|---|---|---|
|
SCT( n = 191) |
MED/RAD (n = 436) |
|||
| N | % | N | % | |
|
Sex, Male |
111 |
58.1 |
229 |
52.5 |
|
Age, years |
49 (12.9) |
56 (13.9) |
||
| Mean (SD) | ||||
| Range |
19-75 |
18-89 |
||
|
Ethnicity, Hispanic/Latino |
2 |
1.0 |
9 |
2.1 |
|
Race, minority or multiple |
13 |
6.8 |
32 |
7.3 |
|
Some college or college graduate |
146 |
76.4 |
299 |
68.6 |
|
Married/Partnered |
138 |
72.3 |
303 |
69.5 |
|
Low annual household income (<=$35,000) |
44 |
23.0 |
101 |
23.2 |
|
Study Group (Intervention)* |
92 |
48.2 |
217 |
49.8 |
|
Incident cancer diagnosis |
134 |
70.2 |
370 |
84.9 |
|
Cancer type |
0 |
0 |
42 |
9.6 |
| Breast | ||||
| GI |
0 |
0 |
80 |
18.3 |
| GU |
0 |
0 |
70 |
16.1 |
| Gyn |
0 |
0 |
49 |
11.2 |
| Head and Neck |
0 |
0 |
53 |
12.2 |
| Leukemia |
88 |
46.1 |
6 |
1.4 |
| Lung |
0 |
0 |
41 |
9.4 |
| Lymphoma |
62 |
32.5 |
40 |
9.2 |
| Myeloma |
38 |
19.9 |
7 |
1.6 |
| Other |
3 |
1.5 |
48 |
11.0 |
|
Days between T1 and T2, days |
|
|
|
|
| Median, range | 42 (14–107) | 41(11–105) | ||
*In the intervention group, Patient-reported quality-of-life issues were automatically displayed on a graphical summary and provided to the clinical team before an on-treatment visit; in the control group, no summary was provided. Details on study design can be found in Berry et al. [16].